Masimo | MASI - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 5.86B 675M 2026-03
Accuray USD 41.89M 7.42M 2024-12
Align Technology USD 736.59M 53M 2026-03
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Avanos Medical USD 94.2M 8.2M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
General Electric Aerospace USD 4.24B 439M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Haemonetics USD 202.39M 7.64M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
Masimo USD 250.8M 3.5M 2026-03
Medtronic USD 6.01B 595M 2026-03
Orthofix International USD 153.28M 4.76M 2025-12
Owens Minor USD 272.05M 20.92M 2025-12
ResMed USD 890.98M 12.26M 2026-03
Steris USD 655.5M 9.6M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12